泰安最佳癫痫治疗方法-【济南癫痫病医院】,NFauFwHg,安徽儿童痫病 专业医院,济宁哪里有治癫痫的医院,江苏到哪治癫痫医院好,安徽哪家医院看羊羔疯病看的好,威海哪里治癫痫病好啊,山东省哪有专治医院羊癫疯专病

VIENNA, Oct. 31 (Xinhua) -- Visiting Chinese President Hu Jintao met his Austrian counterpart Heinz Fischer here Monday and laid out a multi-point proposal to further strengthen bilateral cooperation.During the meeting, Hu spoke highly of the ties between the two countries, saying that China values its relations with Austria and is willing to join hands with Austria to elevate bilateral ties to a higher level.Then he proposed that the two sides enhance their political relationship based on equality and mutual trust, continue with their frequent high-level contacts and steer bilateral relations from a strategic and long-term perspective.The two countries should also expand their mutually beneficial economic and trade relations, he said, while calling for concerted efforts to fight trade protectionism and encourage mutual investment so as to achieve a balanced, diversified and sustainable trade relationship.Visiting Chinese President Hu Jintao (L) shakes hands with his Austrian counterpart Heinz Fischer (R) in Vienna, Austria, Oct. 31, 2011. Hu Jintao held talks with Heinz Fischer in Vienna Monday.China is willing to import more goods from Austria and to work with Austria to seek cooperation with third countries in Central and Eastern Europe, said the Chinese president, who also asked Austria to create favorable conditions for Chinese investors in Austria.Meanwhile, Hu urged Vienna to play a more active role in pushing for the EU's recognition of China's full market economy status and for a lift of the bloc's restrictions on high-tech exports to China.In the culture sphere, the two sides should promote people-to-people exchanges and boost cooperation in culture, eduction and media among others, Hu said.In addition, the two countries should also deepen cooperation in multilateral mechanisms to jointly push for a more just and fairer international political and economic order, Hu said.China, he added, is willing to enhance cooperation and coordination with Austria on important issues such as global economic governance, climate change, energy security and peaceful settlement of international disputes.History has proven that as long as the two sides understand and support each other, and respect each other's social systems and development models, the bilateral relationship can achieve long-term, steady and healthy development, Hu said.Fischer, for his part, said that he fully agrees with Hu's proposal, adding that his country is willing to enhance cooperation with China in culture, science and technology and tourism and expand coordination in the United Nations and other multilateral frameworks.
UNITED NATIONS, Nov. 18 (Xinhua) -- China on Friday voiced its hope that countries concerned "will continue to appropriately address the issue" of the alleged plot to kill Saudi Arabian ambassador to the United States "through dialogue and make joint efforts to maintain peace and stability in the Middle East and the Gulf region."The statement came as Li Baodong, Chinese permanent representative to the United Nations, was addressing the UN General Assembly to explain the Chinese position on the issue after he abstained from voting on the draft resolution on the alleged Iranian involvement in the assassination plot."China hopes countries concerned will continue to appropriately address the issue through dialogue and make joint efforts to maintain peace and stability in the Middle East and the Gulf region," he said."At present, the case is highly complicated and sensitive," Li said. "Parties still have different views over the issue. Any conclusion or action must be based on comprehensive, impartial, objective and transparent investigation and substantial evidence.""Before facts are out, parties should adopt a prudent approach, refrain from jumping to conclusions, and avoid action that may complicate and worsen the situation," he said."China abstained from the vote on the General Assembly draft resolution entitled 'Terrorist Attacks on Internationally Protected Persons'," he said. "We oppose all forms of terrorism, and always stand for compliance with international law and the basis norms governing international relations in handling state-to- state relations as well as effective protection of the safety and security of diplomatic personnel."Earlier on Friday, the UN General Assembly adopted a resolution which expressed deep concerns at the assassination plot and called on Iran "to comply with all of its obligations under international law." Iran strongly denied the allegation.Before or after the vote, countries such as Bolivia, Sudan and Venezuela said that due to a lack of solid evidence to support the allegation, the draft adoption would "create a dangerous precedent " in the international relations.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday revoked its approval of Avastin for treating the breast cancer after concluding that the drug has not been shown to be safe and effective for that use.Avastin will still remain on the market as an approved treatment for certain types of colon, lung, kidney and brain cancer."After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret Hamburg said in a statement. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life. "Avastin's risks include severe high blood pressure; bleeding and hemorrhaging; heart attack or heart failure; and the development of perforations in different parts of the body such as the nose, stomach, and intestines.Avastin was approved for metastatic breast cancer in February 2008 under the FDA's accelerated approval program, which allows a drug to be approved based on data that are not sufficiently complete to permit full approval. After the approval, the drug's sponsor, Genentech, completed two additional clinical trials and submitted the data from those studies to the FDA. These data showed only a small effect on tumor growth without evidence that patients lived any longer or had a better quality of life compared to taking standard chemotherapy alone -- not enough to outweigh the risk of taking the drug.FDA's Center for Drug Evaluation and Research, which is responsible for the approval of this drug, ultimately concluded that the results of these additional studies did not justify continued approval and notified Genentech it was proposing to withdraw approval of the indication.Genentech did not agree with the Center's evaluation of the data and, following the procedures set out in FDA regulations, requested a hearing on the Center's withdrawal proposal, with a decision to be made by the Commissioner. That two-day hearing, which took place June 28-29, included recommendations from the FDA 's Oncologic Drugs Advisory Committee, voting 6-0 in favor of withdrawing approval of Avastin's breast cancer indication.
BEIJING, Dec. 14 (Xinhua) -- The People's Bank of China, the country's central bank, said Wednesday that China will continue its prudent monetary policy next year while making the policy more targeted, flexible and forward-looking.The announcement came after the conclusion of the annual central economic work conference Wednesday morning, which has set economic policy guidelines for the coming year.The central bank will maintain control over the intensity, pace and focus of macroeconomic regulation, make full use of monetary tools, tune up credit supply and promote reasonable growth in social financing, according to a statement posted on its website.The bank will improve credit structure, increase support to key sectors and weak areas, especially to agriculture, small and medium-sized enterprises and affordable housing construction, as well as better serve the real economy.It will continue to perfect its yuan exchange rate formation mechanism, and keep the yuan exchange rates basically stable at a reasonable and balanced level.Meanwhile, the bank will strengthen and improve its foreign exchange management, deepen financial system reforms, prevent and solve financial risks, the statement said.
SAN FRANCISCO, Nov. 14 (Xinhua) -- Google is running a secret research lab in the San Francisco Bay Area, where the tech giant invests to experiment and invent what may be world-changing technologies for the future, U.S. media reported on Monday.According to The New York Times, at the lab dubbed Google X, engineers are working at some 100 projects from robots, smart refrigerators to Internet-enabled dinner plates and a "space elevator," a proposed non-rocket space launch structure.An unnamed Google engineer familiar with the lab told the newspaper that it was run as mysteriously as the CIA with two officers, a nondescript one for logistics on the company's Mountain View campus and one for robots in a secret location.Scientists working at the lab include many roboticists and electrical engineers hired from Microsoft, Nokia labs, Stanford, MIT, Carnegie Mellon and New York University. Google's co-founder Sergey Brin is said to be "deeply involved" in Google X.The lab is reportedly headed by Sebastian Thrun, one of the world's top robotics and artificial intelligence experts. He teaches computer science at Stanford University and invented the world's first self-driving car.A Google spokeswoman would not confirm the existence of the lab, but said Google likes to invest in speculative projects."While the possibilities are incredibly exciting, please do keep in mind that the sums involved are very small by comparison to the investments we make in our core businesses," she told The New York Times.
来源:资阳报